Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Pro Medicus Limited
Pro Medicus makes medical imaging software that hospitals and clinics use to view and share scans like X-rays and MRIs.
Pro Medicus makes the software that lets doctors look at your medical scans. When you get an X-ray, a CT scan, or an MRI, the images have to go somewhere — and that somewhere is usually a system the hospital has to buy. Pro Medicus sells two main products: a radiology information system that handles the paperwork side, like scheduling and reporting, and a viewing platform called Visage 7 that lets doctors pull up huge scan files instantly on any screen.
The money comes from selling these systems to hospitals and imaging centers around the world, then charging ongoing fees to keep them running and supported. Its customers are the big institutions — large hospital networks and imaging groups in the United States, Australia, and Europe. The reason they pick Pro Medicus over rivals is speed. Visage 7 streams giant image files over ordinary networks without the clunky loading delays that older systems are known for, which matters when a radiologist is reading dozens of scans a day. The company is based in Melbourne, Australia, and its big growth push has been in the United States, the world's largest medical imaging market. It has won contracts with some of the biggest names in American healthcare, including major academic hospital systems, and each new win tends to be a multi-year deal that brings recurring revenue rather than a one-off sale. That recurring model is why the business has grown steadily and why investors have paid close attention to it.
Pro Medicus is a small company with a narrow focus — it doesn't make scanners or run hospitals, it just sells the software layer that sits between the machine and the doctor. That focus has been a strength: high margins, little debt, and a product that customers rarely rip out once it's installed. The main risk is competition from larger healthcare software players and the fact that hospital sales cycles are long and lumpy, so growth depends on steadily landing new contracts rather than a steady drip of small customers.
Saved answer · last researched 12 Nov 2026